"Neoplasm Metastasis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Descriptor ID |
D009362
|
| MeSH Number(s) |
C04.697.650 C23.550.727.650
|
| Concept/Terms |
Neoplasm Metastasis- Neoplasm Metastasis
- Metastases, Neoplasm
- Neoplasm Metastases
- Metastasis
- Metastases
- Metastasis, Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Metastasis".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Metastasis".
This graph shows the total number of publications written about "Neoplasm Metastasis" by people in this website by year, and whether "Neoplasm Metastasis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 5 | 7 |
| 1995 | 1 | 5 | 6 |
| 1996 | 1 | 7 | 8 |
| 1997 | 3 | 5 | 8 |
| 1998 | 2 | 9 | 11 |
| 1999 | 2 | 4 | 6 |
| 2000 | 4 | 7 | 11 |
| 2001 | 2 | 5 | 7 |
| 2002 | 3 | 7 | 10 |
| 2003 | 3 | 11 | 14 |
| 2004 | 6 | 24 | 30 |
| 2005 | 5 | 15 | 20 |
| 2006 | 2 | 14 | 16 |
| 2007 | 1 | 12 | 13 |
| 2008 | 8 | 17 | 25 |
| 2009 | 7 | 21 | 28 |
| 2010 | 6 | 20 | 26 |
| 2011 | 5 | 22 | 27 |
| 2012 | 5 | 18 | 23 |
| 2013 | 5 | 30 | 35 |
| 2014 | 9 | 36 | 45 |
| 2015 | 6 | 20 | 26 |
| 2016 | 2 | 34 | 36 |
| 2017 | 2 | 31 | 33 |
| 2018 | 3 | 25 | 28 |
| 2019 | 5 | 39 | 44 |
| 2020 | 4 | 33 | 37 |
| 2021 | 6 | 22 | 28 |
| 2022 | 0 | 5 | 5 |
| 2023 | 1 | 4 | 5 |
| 2024 | 1 | 7 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Metastasis" by people in Profiles.
-
Abiraterone, Olaparib, or Abiraterone + Olaparib in First-Line Metastatic Castration-Resistant Prostate Cancer with DNA Repair Defects (BRCAAway). Clin Cancer Res. 2024 Oct 01; 30(19):4318-4328.
-
Carcinoma-associated mesenchymal stem cells promote ovarian cancer heterogeneity and metastasis through mitochondrial transfer. Cell Rep. 2024 Aug 27; 43(8):114551.
-
A Phase I Trial of Enzalutamide Plus Selective Glucocorticoid Receptor Modulator Relacorilant in Patients with Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2024 Jun 03; 30(11):2384-2392.
-
Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44(3):e433330.
-
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-ß2 levels in metastatic colorectal cancer patients (Alliance). BMC Genomics. 2024 May 14; 25(1):473.
-
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer. Int J Mol Sci. 2024 May 08; 25(10).
-
Radiotherapy Enhances Metastasis Through Immune Suppression by Inducing PD-L1 and MDSC in Distal Sites. Clin Cancer Res. 2024 May 01; 30(9):1945-1958.
-
Palliative Care Use Trends, Racial/Ethnic Disparities, and Overall Survival Differences Among Patients With Metastatic Breast Cancer. J Palliat Med. 2024 Jun; 27(6):763-775.
-
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma. Eur Urol Oncol. 2024 Aug; 7(4):933-943.
-
Clinical Outcomes of Enzalutamide in Metastatic Hormone-sensitive Prostate Cancer in Patients Aged <75 and =75 Years: ARCHES Post Hoc Analysis. Eur Urol Oncol. 2024 Aug; 7(4):860-869.